Cargando…

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurchla, Michelle A., Weilbaecher, Katherine N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518520/ https://www.ncbi.nlm.nih.gov/pubmed/23243611 http://dx.doi.org/10.4161/onci.21060

Ejemplares similares

Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages
por: Su, Shicheng, et al.
Publicado: (2014)

A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
por: Schmiedel, Benjamin Joachim, et al.
Publicado: (2013)

Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015)

Sonic Hedgehog factor Gli1: As good as resistant
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2015)

The hedgehog’s trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors
por: Xie, Jingwu
Publicado: (2014)

COX2 regulation of breast cancer bone metastasis
por: Karavitis, John, et al.
Publicado: (2013)

FSTL1 promotes bone metastasis by causing immune dysfunction
por: Kudo-Saito, Chie
Publicado: (2013)

G-Protein Gα(s) controls medulloblastoma initiation by suppressing sonic hedgehog signaling
por: He, Xuelian, et al.
Publicado: (2014)

p53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis
por: Cain, Jason E., et al.
Publicado: (2020)

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
por: Slaney, Clare Y., et al.
Publicado: (2013)

p16: cycling off the beaten path
por: Buj, Raquel, et al.
Publicado: (2019)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease
por: Dayawansa, Nalin H., et al.
Publicado: (2022)

Sensory nerves: A driver of the vicious cycle in bone metastasis?
por: Yoneda, Toshiyuki, et al.
Publicado: (2021)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

YES, a novel therapeutic target in hepatocellular carcinoma
por: Lapouge, Marjorie, et al.
Publicado: (2022)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Bone marrow provides an environment that prevents suppression of therapeutic graft-vs.-tumor immunity by regulatory T cells
por: Guichelaar, Teun, et al.
Publicado: (2013)

Lung specific X protein as a novel therapeutic target for lung cancer
por: Zheng, Xiaohu, et al.
Publicado: (2015)

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
por: Sawant, Anandi, et al.
Publicado: (2013)

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017)

MIF: metastasis/MDSC-inducing factor?
por: Simpson, Kendra D., et al.
Publicado: (2013)

CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014)

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
por: Noman, Muhammad Zaeem, et al.
Publicado: (2018)

Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
por: Rathore, Richa, et al.
Publicado: (2021)

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis
por: Lim, Su Yin, et al.
Publicado: (2013)

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
por: Cioffi, Michele, et al.
Publicado: (2012)

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
por: Soriani, Alessandra, et al.
Publicado: (2013)

Epigenetic suppression of FBXL7 promotes metastasis
por: Moro, Loredana, et al.
Publicado: (2020)

Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers
por: Yang, Zhengfeng, et al.
Publicado: (2020)

Bad to the bone: B cell acute lymphoblastic leukemia cells mediate bone destruction
por: Rajakumar, Sujeetha A., et al.
Publicado: (2020)

Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)

Tumor spread or siege immunity: dissemination to distant metastasis or not
por: Bindea, Gabriela, et al.
Publicado: (2021)

Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy
por: Dondossola, Eleonora, et al.
Publicado: (2014)

CDK4/6 inhibition in cancer: the cell cycle splicing connection
por: Sheppard, Karen E., et al.
Publicado: (2019)

Stromal CEACAM1 expression regulates colorectal cancer metastasis
por: Arabzadeh, Azadeh, et al.
Publicado: (2012)

TAM macrophages promote growth and metastasis within the cancer ecosystem
por: Zarif, Jelani C, et al.
Publicado: (2014)

Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
por: Suryawanshi, Amol, et al.
Publicado: (2015)

Maintaining cytosolic aspartate levels is a major function of the TCA cycle in proliferating cells
por: Alkan, H. Furkan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s0ean8fmov5lohji2puosp83p5